Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-...

by Mok T., Ladrera G., Srimuninnimit V., Sriuranpong V., Yu C., Thongprasert S., Sandoval-Tan J., Lee J., Fuerte F., Shames D., Klughammer B., Truman M., Perez-Moreno P., Wu Y.
Published 2017